PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Prestige Consumer Healthcare Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$49.71−0.21 (-0.42%)
Close on Oct 19, 2026
- Market cap
- $2.37B
- P/E (TTM)
- 13.9
- Dividend yield
- –
Share price
−$12.38 (−19.94%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Prestige Consumer Healthcare Inc. saw revenue fall 1.4% to $1.10B over the twelve months to Jun 30, 2026. Operating income fell 13.8% to $290.17M, moving the operating margin from 30.0% to 26.3%. Free cash flow was $235.36M, down 12.1% from a year earlier.
Revenue
$1.10B
-1.4% vs. a year earlier
Operating income
$290.17M
-13.8% vs. a year earlier
Free cash flow
$235.36M
-12.1% vs. a year earlier
EPS, diluted
$3.57
-16.2% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.37B
- P/E ratio
- 13.9
- Price to sales
- 2.14
- Price to book
- 1.23
- Dividend yield
- –
- Free cash flow yield
- 9.95%
Fundamentals
- Revenue
- $1.10B
- Net income
- $172.01M
- EPS, diluted
- $3.57
- Free cash flow
- $235.36M
- Book value per share
- $40.26
- Diluted shares
- 48M
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
$1.10B-1.4% YoY
Gross profit
$591.44M-5.9% YoY
Operating income
$290.17M-13.8% YoY
Net income
$172.01M-19.2% YoY
EPS, diluted
$3.57-16.2% YoY
Free cash flow
$235.36M-12.1% YoY
Reported periodTrailing twelve months